Table 4 Baseline demographic characteristics of 12 healthy human subjects and sequence of reference (A) and test (B) products administration.

From: Comparative pharmacokinetics of osmotic-controlled and immediate-release Eperisone tablet formulation in healthy human subjects using a sensitive plasma LC-ESI-MS/MS method

S. No

Volunteer Code

Sequence

Age (Yrs)

Weight (Kg)

Height cm

BMI Kg/m2

1

V1

AB

23

66

175.3

21.5

2

V2

BA

21

67

167.6

23.8

3

V3

AB

20

70

172.7

23.5

4

V4

BA

24

67

170.2

23.1

5

V5

AB

24

68

165.1

24.9

6

V6

BA

22

64

170.2

22.1

7

V7

AB

22

69

175.3

22.5

8

V8

BA

22

71

177.8

22.5

9

V9

AB

18

66

170.2

22.8

10

V10

BA

24

72

175.3

23.4

11

V11

AB

21

67

172.7

22.5

12

V12

BA

23

63

167.6

21

Back to article page